Cargando…

The clinical significance of UBE2C gene in progression of renal cell carcinoma

Renal cell carcinoma (RCC), with high morbidity and mortality, is one of the top ten serious cancers. Due to limited therapies and little knowledge about the mechanism underlying RCC, overall survival of RCC patients is poor. UBE2C is a member of ubiquitin modification system and promotes carcinogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhiping, Wang, Lanfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054571/
https://www.ncbi.nlm.nih.gov/pubmed/33782624
http://dx.doi.org/10.4081/ejh.2021.3196
_version_ 1783680315841052672
author Chen, Zhiping
Wang, Lanfeng
author_facet Chen, Zhiping
Wang, Lanfeng
author_sort Chen, Zhiping
collection PubMed
description Renal cell carcinoma (RCC), with high morbidity and mortality, is one of the top ten serious cancers. Due to limited therapies and little knowledge about the mechanism underlying RCC, overall survival of RCC patients is poor. UBE2C is a member of ubiquitin modification system and promotes carcinogenesis in cancer, but its role in RCC is unknown. Based on the TCGA (The Cancer Genome Atlas) data, UBE2C was over-expressed in a total of 525 RCC tissues and displayed higher expression in advanced tissues (stage IV vs stage I, p<0.05). RT-qPCR and IHC analysis confirmed over-expression of UBE2C in 90 of clinical RCC tissues. Further, UBE2C was associated with clinical factors including TNM stage, gender, and pathological stage. And higher UBE2C expression predicted shorter overall survival and progression-free survival. Both univariate and multivariate COX analysis suggested UBE2C as a critical gene in RCC. Then GO and KEGG analysis showed that cell cycle and DNA replication pathways were two top signaling pathways affected by UBE2C. In vitro assay showed that knockdown of UBE2C in 786-O cells inhibited proliferation and migration significantly. Therefore, this study proves that UBE2C is an important gene in RCC and is essential to proliferation and migration of RCC.
format Online
Article
Text
id pubmed-8054571
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher PAGEPress Publications, Pavia, Italy
record_format MEDLINE/PubMed
spelling pubmed-80545712021-04-22 The clinical significance of UBE2C gene in progression of renal cell carcinoma Chen, Zhiping Wang, Lanfeng Eur J Histochem Article Renal cell carcinoma (RCC), with high morbidity and mortality, is one of the top ten serious cancers. Due to limited therapies and little knowledge about the mechanism underlying RCC, overall survival of RCC patients is poor. UBE2C is a member of ubiquitin modification system and promotes carcinogenesis in cancer, but its role in RCC is unknown. Based on the TCGA (The Cancer Genome Atlas) data, UBE2C was over-expressed in a total of 525 RCC tissues and displayed higher expression in advanced tissues (stage IV vs stage I, p<0.05). RT-qPCR and IHC analysis confirmed over-expression of UBE2C in 90 of clinical RCC tissues. Further, UBE2C was associated with clinical factors including TNM stage, gender, and pathological stage. And higher UBE2C expression predicted shorter overall survival and progression-free survival. Both univariate and multivariate COX analysis suggested UBE2C as a critical gene in RCC. Then GO and KEGG analysis showed that cell cycle and DNA replication pathways were two top signaling pathways affected by UBE2C. In vitro assay showed that knockdown of UBE2C in 786-O cells inhibited proliferation and migration significantly. Therefore, this study proves that UBE2C is an important gene in RCC and is essential to proliferation and migration of RCC. PAGEPress Publications, Pavia, Italy 2021-03-29 /pmc/articles/PMC8054571/ /pubmed/33782624 http://dx.doi.org/10.4081/ejh.2021.3196 Text en ©Copyright: the Author(s) https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Article
Chen, Zhiping
Wang, Lanfeng
The clinical significance of UBE2C gene in progression of renal cell carcinoma
title The clinical significance of UBE2C gene in progression of renal cell carcinoma
title_full The clinical significance of UBE2C gene in progression of renal cell carcinoma
title_fullStr The clinical significance of UBE2C gene in progression of renal cell carcinoma
title_full_unstemmed The clinical significance of UBE2C gene in progression of renal cell carcinoma
title_short The clinical significance of UBE2C gene in progression of renal cell carcinoma
title_sort clinical significance of ube2c gene in progression of renal cell carcinoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054571/
https://www.ncbi.nlm.nih.gov/pubmed/33782624
http://dx.doi.org/10.4081/ejh.2021.3196
work_keys_str_mv AT chenzhiping theclinicalsignificanceofube2cgeneinprogressionofrenalcellcarcinoma
AT wanglanfeng theclinicalsignificanceofube2cgeneinprogressionofrenalcellcarcinoma
AT chenzhiping clinicalsignificanceofube2cgeneinprogressionofrenalcellcarcinoma
AT wanglanfeng clinicalsignificanceofube2cgeneinprogressionofrenalcellcarcinoma